Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Veracyte (VCYT) Return on Equity (2016 - 2025)

Historic Return on Equity for Veracyte (VCYT) over the last 13 years, with Q3 2025 value amounting to 0.02%.

  • Veracyte's Return on Equity rose 300.0% to 0.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02%, marking a year-over-year increase of 300.0%. This contributed to the annual value of 0.02% for FY2024, which is 900.0% up from last year.
  • Per Veracyte's latest filing, its Return on Equity stood at 0.02% for Q3 2025, which was up 300.0% from 0.02% recorded in Q2 2025.
  • Veracyte's 5-year Return on Equity high stood at 0.03% for Q1 2025, and its period low was 0.09% during Q1 2021.
  • For the 5-year period, Veracyte's Return on Equity averaged around 0.03%, with its median value being 0.04% (2022).
  • Per our database at Business Quant, Veracyte's Return on Equity tumbled by -400bps in 2023 and then surged by 900bps in 2024.
  • Quarter analysis of 5 years shows Veracyte's Return on Equity stood at 0.07% in 2021, then soared by 50bps to 0.03% in 2022, then tumbled by -106bps to 0.07% in 2023, then surged by 129bps to 0.02% in 2024, then rose by 19bps to 0.02% in 2025.
  • Its last three reported values are 0.02% in Q3 2025, 0.02% for Q2 2025, and 0.03% during Q1 2025.